
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.
Saphetor Sa, A Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Maarten Kempen as Chief Commercial Officer, effective February 1st, 2023. Kempen will be responsible...
Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.
Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...
Press Releases Partnerships News
Conferences Partnerships Events News
RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...
Press Releases Partnerships News
Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...
Press Releases Partnerships News
Lausanne, Switzerland, July 12, 2022 - Saphetor, a global precision medicine company and the creator of VarSome, The Human Genomics Community and variant interpretation platform, announced today a partnership with PTC Therapeutics International...
Saphetor was featured in Nature Portfolio's Biopharma Dealmakers this week. The article explains how and why Saphetor developed VarSome. You can read the full article here.
VarSome Suite is brought to you by Saphetor SA.
© 2023 Saphetor SA – All Rights Reserved.